Yuan Zhi
Stock Analyst at B. Riley Securities
(2.81)
# 1,663
Out of 5,147 analysts
32
Total ratings
38.71%
Success rate
2.2%
Average return
Main Sectors:
Stocks Rated by Yuan Zhi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RADX Radiopharm Theranostics | Reiterates: Buy | $13 → $16 | $4.99 | +220.64% | 3 | Dec 16, 2025 | |
| RDNT RadNet | Maintains: Buy | $71 → $87 | $69.81 | +24.62% | 2 | Dec 1, 2025 | |
| TNGX Tango Therapeutics | Maintains: Buy | $8 → $14 | $11.14 | +25.67% | 3 | Nov 18, 2025 | |
| CATX Perspective Therapeutics | Maintains: Buy | $12 → $11 | $5.40 | +103.70% | 4 | Nov 18, 2025 | |
| MIR Mirion Technologies | Reiterates: Buy | $17 → $22 | $21.61 | +1.80% | 3 | Jul 23, 2025 | |
| TOI The Oncology Institute | Initiates: Buy | $6 | $2.89 | +107.61% | 1 | Jul 16, 2025 | |
| HYPR Hyperfine | Maintains: Buy | $1.2 → $1 | $1.07 | -6.54% | 2 | May 15, 2025 | |
| AGEN Agenus | Maintains: Buy | $42 → $18 | $3.33 | +440.54% | 2 | Aug 14, 2024 | |
| CYRX Cryoport | Upgrades: Buy | $19 → $15 | $8.42 | +78.15% | 4 | Jul 31, 2024 | |
| CTSO Cytosorbents | Reiterates: Buy | $3 | $0.75 | +298.67% | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 → $79 | $26.98 | +192.81% | 3 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $16 | $1.18 | +1,255.93% | 4 | Dec 11, 2023 |
Radiopharm Theranostics
Dec 16, 2025
Reiterates: Buy
Price Target: $13 → $16
Current: $4.99
Upside: +220.64%
RadNet
Dec 1, 2025
Maintains: Buy
Price Target: $71 → $87
Current: $69.81
Upside: +24.62%
Tango Therapeutics
Nov 18, 2025
Maintains: Buy
Price Target: $8 → $14
Current: $11.14
Upside: +25.67%
Perspective Therapeutics
Nov 18, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $5.40
Upside: +103.70%
Mirion Technologies
Jul 23, 2025
Reiterates: Buy
Price Target: $17 → $22
Current: $21.61
Upside: +1.80%
The Oncology Institute
Jul 16, 2025
Initiates: Buy
Price Target: $6
Current: $2.89
Upside: +107.61%
Hyperfine
May 15, 2025
Maintains: Buy
Price Target: $1.2 → $1
Current: $1.07
Upside: -6.54%
Agenus
Aug 14, 2024
Maintains: Buy
Price Target: $42 → $18
Current: $3.33
Upside: +440.54%
Cryoport
Jul 31, 2024
Upgrades: Buy
Price Target: $19 → $15
Current: $8.42
Upside: +78.15%
Cytosorbents
May 15, 2024
Reiterates: Buy
Price Target: $3
Current: $0.75
Upside: +298.67%
Feb 1, 2024
Maintains: Buy
Price Target: $61 → $79
Current: $26.98
Upside: +192.81%
Dec 11, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $1.18
Upside: +1,255.93%